NAD+ Ameliorates Inflammation-Induced Epithelial Barrier Dysfunction in Cultured Enterocytes and Mouse Ileal Mucosa

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 2, 2003, Pages 443-449

  Han, Xiaonan ^a   Uchiyama, Takashi ^a   Sappington, Penny L ^a   Yaguchi, Arino ^a   Yang, Runkuan ^b   Fink, Mitchell P ^a   Delude, Russell L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b 615 Scaife Hall ^*

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OCCLUDIN; PURINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; BIOSYNTHESIS; CELL STIMULATION; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG TARGETING; ENZYME INDUCTION; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; ILEUM MUCOSA; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; INFLAMMATION; INTESTINE CELL; INTESTINE EPITHELIUM; MALE; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MOLECULAR WEIGHT; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

ANIMALS; CACO-2 CELLS; DRUG INTERACTIONS; ENTEROCYTES; HUMANS; ILEUM; IMMUNIZATION; INFLAMMATION; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; NAD; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; TIGHT JUNCTIONS;

EID: 0142148207     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.056556     Document Type: Article

References (32)

1. Anderson JM and Van Itallie CM (1995) Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 269:G467-G475.
2. Balducci E and Micossi LG (2002) NAD-dependent inhibition of the NAD-glycohydrolase activity in A549 cells. Mol Cell Biochem 233:127-132.
3. Beers KW, Chini EN, Lee HC, and Dousa TP (1995) Metabolism of cyclic ADP-ribose in opossum kidney renal epithelial cells. Am J Physiol 268:C741-C746.
4. Bruzzone S, Franco L, Guida L, Zocchi E, Contini P, Bisso A, Usai C, and De Flora A (2001) A self-restricted CD38-connexin 43 cross-talk affects NAD+ and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts. J Biol Chem 276:48300-48308.
5. Deaglio S, Mehta K, and Malavasi F (2001) Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res 25:1-12.
6. Delude RL, Fenton MJ, Savedra R Jr, Perera PY, Vogel SN, Thieringer R, and Golenbock DT (1994) CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity. J Biol Chem 269:22253-22260.
7. Duncan RL and Turner CH (1995) Mechanotransduction and the functional response of bone to mechanical strain. Calcif Tissue Int 57:344-358.
8. Franco L, Guida L, Bruzzone S, Zocchi E, Usai C, and De Flora A (1998) The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes. FASEB J 12:1507-1520.
9. + and cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts. J Biol Chem 276:21642-21648.
10. 2+ release in T lymphocyte cell lines. J Immunol 155:3353-3359.
11. Han X, Fink MP, and Delude RL (2003a) Proinflammatory cytokines cause NO-dependent and independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19:229-237.
12. Han X, Fink MP, Uchiyama T, Yang R, and Delude RL (2003b) Increased iNOS activity is essential for the development of hepatic epithelial tight junction dysfunction in endotoxemic mice. Am J Physiol Gastrointest Liver Physiol, in press. DOI: 10.1152/ajpgi.00231.2003.
13. Hedeskov CJ (1980) Mechanism of glucose-induced insulin secretion. Physiol Rev 60:442-509.
14. Higashida H, Hashii M, Yokoyama S, Hoshi N, Chen XL, Egorova A, Noda M, and Zhang JS (2001) Cyclic ADP-ribose as a second messenger revisited from a new aspect of signal transduction from receptors to ADP-ribosyl cyclase. Pharmacol Ther 90:283-296.
15. Kato I, Takasawa S, Akabane A, Tanaka O, Abe H, Takamura T, Suzuki Y, Nata K, Yonekura H, Yoshimoto T, et al. (1995) Regulatory role of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in insulin secretion by glucose in pancreatic beta cells. Enhanced insulin secretion in CD38-expressing transgenic mice. J Biol Chem 270:30045-30050.
16. 2 consumption by immunostimulated Caco-2 cells. Am J Physiol 282:L1082-L1091.
17. Kim UH, Kim MK, Kim JS, Han MK, Park BH, and Kim HR (1993) Purification and characterization of NAD glycohydrolase from rabbit erythrocytes. Arch Biochem Biophys 305:147-152.
18. Okamoto H and Takasawa S (2002) Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in beta-cells. Diabetes Suppl 3:S462-S473.
19. Parker FG, Barnes EN, and Kaye GI (1974) The pericryptal fibroblast sheath. IV. Replication, migration and differentiation of the subepithelial fibroblasts of the crypt and villus of the rabbit jejunum. Gastroenterology 67:607-621.
20. + induces calcium signaling and apoptosis in human osteoblastic cells. Biochem Biophys Res Commun 285:1226-1231.
21. Sajjadi FG, Takabayashi K, Foster AC, Domingo RC, and Firestein GS (1996) Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. J Immunol 156:3435-3442.
22. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, and Tsukita S (1997) Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 137:1393-1401.
23. Sappington PL, Han X, Yang R, Delude RL, and Fink MP (2003) Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated caco-2 enterocytic monolayers. J Pharmacol Exp Ther 304:464-476.
24. Sappington PL, Yang R, Yang H, Tracey KJ, Delude RL, and Fink MP (2002) HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 123:790-802.
25. Takasawa S, Nata K, Yonekura H, and Okamoto H (1993a) Cyclic ADP-ribose in insulin secretion from pancreatic beta cells. Science (Wash DC) 259:370-373.
26. Takasawa S, Tohgo A, Noguchi N, Koguma T, Nata K, Sugimoto T, Yonekura H, and Okamoto H (1993b) Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J Biol Chem 268:26052-26054.
27. Tohgo A, Munakata H, Takasawa S, Nata K, Akiyama T, Hayashi N, and Okamoto H (1997) Lysine 129 of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) participates in the binding of ATP to inhibit the cyclic ADP-ribose hydrolase. J Biol Chem 272:3879-3882.
28. Tsukita S, Furuse M, and Itoh M (2001) Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2:285-293.
29. Unno N and Fink MP (1998) Intestinal epithelial hyperpermeability. Mechanisms and relevance to disease. Gastroenterol Clin North Am 27:289-307.
30. Unno N, Menconi MJ, Smith M, and Fink MP (1995) Nitric oxide mediates interferon-gamma-induced hyperpermeability in cultured human intestinal epithelial monolayers. Crit Care Med 23:1170-1176.
31. Youakim A and Ahdieh M (1999) Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 276:G1279-G1288.
32. Zolotarevsky Y, Hecht G, Koutsouris A, Gonzalez DE, Quan C, Tom J, Mrsny RJ, and Turner JR (2002) A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 123:163-172.